Angiography Equipment Market

Angiography Equipment Market Research Report Information By Product (Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, and Angiography Accessories), By Procedure (Coronary Angiography, Endovascular Angiography, Neuroangiography, and Onco-angiography), By Application (Diagnostics, and Therapeutics,), By End-User (Hospitals & Clinics, Diagnostic Centers, Imaging Centers, Research Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035
ID: MRFR/MED/4648-HCR
100 Pages
Rahul Gotadki, Kinjoll Dey
Last Updated: May 15, 2026
Angiography Equipment Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.2%
2024 Market Size$ 9.41 Billion
2025 Market Size$ 9.89 Billion
2035 Market Size$ 16.43 Billion

Key Players

Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Medtronic
Boston Scientific
Trends
  • Technological Advancements
  • Minimally Invasive Techniques
  • Integration of Artificial Intelligence
Opportunities
  • Market Growth Projections
  • Technological Advancements
  • Increasing Healthcare Expenditure
Request Free Sample

Angiography Equipment Market Summary

As per MRFR analysis, the Angiography Equipment Market Size was estimated at 9.41 USD Billion in 2024. The Angiography Equipment industry is projected to grow from 9.89 USD Billion in 2025 to 16.43 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Angiography Equipment Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements are enhancing imaging quality and procedural efficiency in the angiography equipment market.
  • The North American region remains the largest market, while the Asia-Pacific region is recognized as the fastest-growing area for angiography equipment.
  • The cardiovascular segment dominates the market, whereas the neurovascular segment is experiencing the fastest growth due to rising awareness and treatment options.
  • Key market drivers include the rising incidence of cardiovascular diseases and the growing demand for minimally invasive procedures.

Market Size & Forecast

2024 Market Size 9.41 (USD Billion)
2035 Market Size 16.43 (USD Billion)
CAGR (2025 - 2035) 5.2%

Major Players

Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Medtronic (US), Boston Scientific (US), Fujifilm (JP), Hitachi Medical Systems (JP), Hologic (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Angiography Equipment Market Drivers

Market Growth Projections

The Global Angiography Equipment Market Industry is projected to experience substantial growth over the next decade. With a market value expected to reach 9.41 USD Billion in 2024 and 16.4 USD Billion by 2035, the industry is poised for a robust expansion. The compound annual growth rate of 5.2% from 2025 to 2035 suggests a steady increase in demand for angiography systems. This growth is likely driven by technological advancements, rising healthcare expenditures, and an increasing prevalence of cardiovascular diseases. As the market evolves, it will be essential for stakeholders to adapt to changing trends and invest in innovative solutions to meet the growing needs of healthcare providers and patients.

Technological Advancements

The Global Angiography Equipment Market Industry is experiencing rapid technological advancements, which are enhancing the efficacy and precision of diagnostic procedures. Innovations such as 3D imaging, real-time visualization, and advanced catheter designs are becoming increasingly prevalent. These developments not only improve patient outcomes but also streamline workflows in healthcare facilities. As a result, the market is projected to reach 9.41 USD Billion in 2024, driven by the demand for more sophisticated imaging solutions. The integration of artificial intelligence and machine learning into angiography systems further indicates a shift towards more automated and accurate diagnostic tools, potentially revolutionizing the industry.

Increasing Healthcare Expenditure

The Global Angiography Equipment Market Industry is benefiting from increasing healthcare expenditure across various regions. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical equipment. This trend is particularly evident in emerging economies, where improved access to healthcare services is driving demand for angiography systems. The projected compound annual growth rate of 5.2% from 2025 to 2035 indicates a robust market trajectory, fueled by these investments. Enhanced funding for healthcare initiatives is likely to facilitate the adoption of cutting-edge angiography technologies, thereby improving diagnostic capabilities and patient care.

Rising Prevalence of Cardiovascular Diseases

The Global Angiography Equipment Market Industry is significantly influenced by the rising prevalence of cardiovascular diseases, which are among the leading causes of mortality worldwide. As the global population ages, the incidence of conditions such as coronary artery disease and peripheral artery disease is expected to increase. This trend necessitates the use of angiography equipment for accurate diagnosis and treatment planning. The market's growth is further supported by healthcare initiatives aimed at improving cardiovascular health, leading to an anticipated market value of 16.4 USD Billion by 2035. Consequently, the demand for advanced angiography systems is likely to surge, reflecting the urgent need for effective diagnostic tools.

Regulatory Support and Reimbursement Policies

The Global Angiography Equipment Market Industry is positively impacted by supportive regulatory frameworks and reimbursement policies that facilitate the adoption of advanced medical technologies. Governments and health organizations are increasingly recognizing the importance of angiography in diagnosing and treating cardiovascular diseases, leading to favorable reimbursement rates for these procedures. This support encourages healthcare providers to invest in state-of-the-art angiography equipment, thereby driving market growth. As reimbursement policies evolve to cover more advanced technologies, the market is likely to see increased adoption rates, further enhancing the accessibility and affordability of angiography services for patients.

Growing Demand for Minimally Invasive Procedures

The Global Angiography Equipment Market Industry is witnessing a growing demand for minimally invasive procedures, which are preferred by both patients and healthcare providers. These procedures typically result in shorter recovery times, reduced hospital stays, and lower overall costs. Angiography plays a crucial role in facilitating such interventions, as it allows for precise imaging and guidance during procedures. The increasing awareness of the benefits of minimally invasive techniques is likely to drive the adoption of advanced angiography systems. As a result, the market is expected to expand significantly, aligning with the broader trend towards patient-centered care and improved surgical outcomes.

Market Segment Insights

By Application: Cardiovascular (Largest) vs. Neurovascular (Fastest-Growing)

The Angiography Equipment Market showcases a diverse application landscape with Cardiovascular applications holding the largest market share. This segment is propelled by the rising prevalence of cardiovascular diseases and the subsequent demand for precise diagnostic tools. Other segments, such as Neurovascular, Peripheral, Oncology, and Gastrointestinal, contribute significantly, but Cardiovascular distinctly leads due to its established usage in hospitals and clinics. As healthcare systems continue to invest in advanced imaging technologies, these applications are poised for substantial growth. In terms of growth trends, the Neurovascular segment stands out as the fastest-growing area within angiography equipment. Driven by technological advancements and increasing awareness about neurovascular disorders, investments in this segment are translating into innovative solutions. Furthermore, the rising incidence of aneurysms and strokes is encouraging healthcare providers to adopt state-of-the-art neuroangiography tools, ensuring better patient outcomes and fueling further market expansion.

Cardiovascular (Dominant) vs. Neurovascular (Emerging)

The Cardiovascular segment is the dominant force in the Angiography Equipment Market, characterized by its long-standing application in diagnosing and treating heart-related conditions. With established techniques such as catheter angiography and emerging minimally invasive procedures, this segment benefits from robust clinical adoption. On the other hand, the Neurovascular segment represents an emerging area, rapidly gaining traction due to an increase in awareness of neuro-related diseases like stroke and cerebral aneurysms. This segment is not only expanding its technological portfolio but also enhancing procedural efficiencies, making neuroangiography an area of focus for innovation and investment as healthcare providers recognize the need for timely interventions in neurological emergencies.

By End Use: Hospitals (Largest) vs. Diagnostic Imaging Centers (Fastest-Growing)

In the Angiography Equipment Market, hospitals account for the largest share, driven by their extensive patient base and comprehensive diagnostic services. They are the primary consumers of angiography equipment, using it for various procedures, including interventional cardiology and neurology. Diagnostic imaging centers, while smaller in share, are rapidly gaining traction, providing specialized imaging services that attract an increasing volume of referrals from healthcare providers.

Hospitals (Dominant) vs. Diagnostic Imaging Centers (Emerging)

Hospitals represent the dominant segment in the Angiography Equipment Market, recognized for their capability to provide a wide array of interventional procedures, housing advanced imaging technology. Their established infrastructure supports frequent angiography usage, resulting in high demand for the latest equipment. On the other hand, diagnostic imaging centers are emerging as significant players, capitalizing on the trend toward outpatient services and specialized imaging capabilities. They often focus on cost-effective procedures, attracting a demographic increasingly seeking non-invasive diagnostics. Together, these segments illustrate a dynamic healthcare landscape, with hospitals maintaining dominance while imaging centers grow rapidly.

By Product Type: Angiography Systems (Largest) vs. Angiography Catheters (Fastest-Growing)

The Angiography Equipment Market is witnessing a significant distribution of market shares among its various product types. Angiography Systems hold the largest portion of the market, driven by their essential role in diagnostic and therapeutic procedures. Meanwhile, Angiography Catheters are gaining traction, particularly in minimally invasive procedures, which has lead to their rapid growth within the segment. This shift indicates a wider acceptance of advanced medical technologies within healthcare practices.

Product Comparison: Angiography Systems (Dominant) vs. Angiography Contrast Media (Emerging)

Angiography Systems are currently the dominant force in the Angiography Equipment Market due to their comprehensive capabilities and extensive use in hospitals and diagnostic labs. They facilitate real-time imaging and accurate diagnosis, which are critical for effective patient management. On the other hand, Angiography Contrast Media is becoming an emerging segment as it plays a vital role in enhancing the visibility of vascular structures during procedures. As technologies advance, the demand for high-quality contrast agents is expected to rise, driven by the need for improved imaging outcomes and patient safety.

By Technology: Digital Angiography (Largest) vs. Computed Tomography Angiography (Fastest-Growing)

In the Angiography Equipment Market, Digital Angiography holds the largest share, dominating the segment due to its advanced imaging capabilities and efficiency in diagnosing vascular conditions. Computed Tomography Angiography, while not as dominant, is experiencing rapid growth, increasingly adopted for its non-invasive approach and detailed visualization of blood vessels, essential for accurate diagnosis and treatment planning. As a whole, the technology segment showcases strong market dynamics with a balanced distribution among the various techniques, catering to diverse clinical needs.

Technology: Digital Angiography (Dominant) vs. Computed Tomography Angiography (Emerging)

Digital Angiography is recognized for its superior image quality and reduced radiation exposure, making it a preferred choice among healthcare professionals for precise vascular assessments. On the other hand, Computed Tomography Angiography is gaining traction due to its non-invasive nature and ability to produce rapid results, catering to the increasing demand for patient-centered healthcare solutions. Both technologies exhibit unique advantages, with Digital Angiography maintaining its position as the dominant approach in the angiography landscape, while Computed Tomography Angiography is poised for substantial growth as technological advancements continue to enhance its capabilities and accessibility.

By Patient Demographics: Adult (Largest) vs. Geriatric (Fastest-Growing)

The Patient Demographics segment in the Angiography Equipment Market is primarily dominated by the Adult population, which constitutes the largest share among the various demographics. Adult patients are frequently the primary focus in cardiology and vascular procedures, resulting in a significant proportion of angiography procedures performed on this demographic. In contrast, the Pediatric segment, while smaller, is also a vital demographic that is steadily growing. Growth trends in the Patient Demographics segment are largely driven by an increase in cardiovascular diseases among older adults, leading to heightened demand for angiographic procedures targeting the Geriatric population. This demographic is steadily becoming the fastest-growing segment due to aging populations and rising chronic conditions such as hypertension and diabetes that necessitate angiography. The pediatric segment, though less in market share, benefits from technological advancements tailored towards safer imaging practices for younger patients, reflecting an evolving market landscape.

Adult (Dominant) vs. Geriatric (Emerging)

The Adult demographic remains dominant in the Angiography Equipment Market due to the higher prevalence of cardiovascular diseases and a significant number of invasive procedures required for this age group. This segment's robust clinical applications heavily influence the market with advancements in imaging technologies, ensuring high-quality diagnostics and treatment. On the other hand, the Geriatric demographic is emerging rapidly, driven by an increase in life expectancy and the prevalence of age-related diseases. While the market is adapting to meet the specific needs of older patients, such as increased accessibility and safety measures, it also addresses the complexities of co-morbidities. This shift towards accommodating geriatric patients indicates a dynamic market where manufacturers are innovating to enhance patient outcomes and operational efficiency.

Get more detailed insights about Angiography Equipment Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the angiography equipment market, holding a significant share of 4.7 billion in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on technological innovations. Regulatory support and favorable reimbursement policies further catalyze market expansion, making it a hub for medical advancements. The competitive landscape in North America is robust, featuring key players such as GE Healthcare and Siemens Healthineers. The U.S. stands out as the largest market, supported by high healthcare spending and a growing aging population. Companies are investing heavily in R&D to introduce cutting-edge technologies, ensuring they remain at the forefront of the angiography equipment sector.

Europe : Emerging Market with Growth Potential

Europe's angiography equipment market is valued at 2.8 billion, reflecting a growing demand for advanced medical imaging solutions. Factors such as an aging population, rising incidences of chronic diseases, and increasing healthcare expenditure are driving this growth. Regulatory frameworks in the EU are also evolving to support innovation and improve patient outcomes, enhancing market dynamics. Leading countries in this region include Germany, France, and the UK, where major players like Philips Healthcare and Siemens Healthineers are actively competing. The competitive landscape is characterized by strategic partnerships and collaborations aimed at enhancing product offerings. The European market is poised for further growth as healthcare providers increasingly adopt advanced angiography technologies to improve diagnostic accuracy and patient care.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific angiography equipment market, valued at 1.8 billion, is experiencing rapid growth due to increasing healthcare investments and a rising prevalence of cardiovascular diseases. Countries like China and India are leading this growth, supported by government initiatives aimed at improving healthcare infrastructure. The demand for minimally invasive procedures is also propelling the adoption of angiography technologies across the region. The competitive landscape is evolving, with key players such as Canon Medical Systems and Fujifilm expanding their presence. The region is characterized by a mix of established companies and emerging startups, fostering innovation. As healthcare systems modernize, the Asia-Pacific market is expected to witness significant advancements in angiography equipment, enhancing diagnostic capabilities and patient outcomes.

Middle East and Africa : Untapped Market with Potential

The Middle East and Africa angiography equipment market, valued at 0.11 billion, presents significant growth opportunities driven by increasing healthcare investments and a rising burden of chronic diseases. Governments in the region are focusing on enhancing healthcare infrastructure and access to advanced medical technologies, which is expected to boost market growth. Regulatory initiatives are also being introduced to facilitate the adoption of innovative healthcare solutions. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities adopting angiography technologies. The competitive landscape is gradually evolving, with both international and local players vying for market share. As healthcare systems improve, the demand for advanced angiography equipment is anticipated to rise, paving the way for future growth in this region.

Angiography Equipment Market Regional Image

Key Players and Competitive Insights

The Angiography Equipment Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for minimally invasive procedures. Key players such as Siemens Healthineers (DE), GE Healthcare (US), and Philips Healthcare (NL) are strategically positioned to leverage innovation and expand their market presence. Siemens Healthineers (DE) focuses on enhancing imaging quality and workflow efficiency, while GE Healthcare (US) emphasizes digital transformation and AI integration in its product offerings. Philips Healthcare (NL) is actively pursuing partnerships to enhance its technological capabilities, thereby shaping a competitive environment that prioritizes innovation and collaboration.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and services, catering to various customer needs while fostering competition among established and emerging players.

In November Siemens Healthineers (DE) announced the launch of its latest angiography system, which integrates advanced AI algorithms to improve diagnostic accuracy. This strategic move not only reinforces Siemens' commitment to innovation but also positions the company to capture a larger share of the growing demand for precision medicine. The incorporation of AI into angiography equipment is likely to enhance patient outcomes and streamline clinical workflows, thereby solidifying Siemens' competitive edge.

In October GE Healthcare (US) unveiled a new partnership with a leading telehealth provider to integrate remote monitoring capabilities into its angiography systems. This collaboration is significant as it reflects GE's strategy to enhance patient care through digital solutions, aligning with the broader trend of telemedicine. By incorporating remote monitoring, GE Healthcare (US) aims to improve patient engagement and streamline follow-up care, which could lead to better health outcomes and increased customer loyalty.

In September Philips Healthcare (NL) expanded its product portfolio by acquiring a startup specializing in advanced imaging software. This acquisition is indicative of Philips' strategy to bolster its technological capabilities and enhance its competitive positioning in the angiography market. By integrating innovative software solutions, Philips aims to provide more comprehensive imaging solutions that meet the evolving needs of healthcare providers, thereby enhancing its market appeal.

As of December the competitive trends in the Angiography Equipment Market are increasingly defined by digitalization, sustainability, and AI integration. Strategic alliances are playing a crucial role in shaping the current landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift underscores the importance of developing cutting-edge solutions that not only meet regulatory standards but also enhance patient care and operational efficiency.

Key Companies in the Angiography Equipment Market include

Industry Developments

  • Q2 2024: Siemens Healthineers launches ARTIS icono ceiling, a new ceiling-mounted angiography system Siemens Healthineers announced the launch of the ARTIS icono ceiling, a new ceiling-mounted angiography system designed to support a wide range of minimally invasive procedures, expanding its ARTIS icono family of angiography systems.
  • Q2 2024: Philips introduces Azurion neuro biplane system for neurovascular procedures Philips launched the Azurion neuro biplane system, a new angiography platform designed to enhance neurovascular imaging and workflow, supporting complex stroke and aneurysm interventions.
  • Q2 2024: Canon Medical launches Alphenix Sky+, a new ceiling-mounted angiography system Canon Medical Systems announced the launch of Alphenix Sky+, a new ceiling-mounted angiography system with advanced imaging capabilities for interventional radiology and cardiology.
  • Q2 2024: GE HealthCare receives FDA 510(k) clearance for Allia IGS Pulse, its next-generation image-guided system GE HealthCare announced it has received FDA 510(k) clearance for the Allia IGS Pulse, a new image-guided system for angiography procedures, featuring enhanced imaging and workflow automation.
  • Q3 2024: Siemens Healthineers opens new manufacturing facility for angiography systems in Forchheim, Germany Siemens Healthineers inaugurated a new manufacturing facility in Forchheim, Germany, dedicated to the production of advanced angiography systems to meet growing global demand.
  • Q3 2024: Philips and Medtronic announce partnership to advance image-guided therapy solutions Philips and Medtronic announced a strategic partnership to co-develop and integrate advanced image-guided therapy solutions, including next-generation angiography platforms.
  • Q4 2024: Canon Medical receives CE mark for Alphenix Sky+ angiography system Canon Medical Systems received CE mark approval for its Alphenix Sky+ angiography system, enabling its commercial launch across the European Union.
  • Q4 2024: GE HealthCare and Mayo Clinic sign multi-year agreement for advanced angiography imaging solutions GE HealthCare and Mayo Clinic entered a multi-year agreement to deploy advanced angiography imaging solutions across Mayo Clinic’s facilities, aiming to enhance cardiovascular and neurovascular care.
  • Q1 2025: Siemens Healthineers receives FDA clearance for ARTIS icono ceiling angiography system Siemens Healthineers received FDA clearance for its ARTIS icono ceiling angiography system, allowing for its commercial distribution in the United States.
  • Q1 2025: Philips launches next-generation Azurion platform with AI-powered workflow for angiography Philips introduced a next-generation Azurion platform featuring AI-powered workflow enhancements for angiography procedures, aiming to improve efficiency and clinical outcomes.
  • Q2 2025: Canon Medical opens new R&D center for interventional imaging in Otawara, Japan Canon Medical Systems opened a new research and development center in Otawara, Japan, focused on advancing interventional imaging technologies, including angiography equipment.
  • Q2 2025: GE HealthCare launches Allia IGS Pulse in Europe following CE mark approval GE HealthCare launched the Allia IGS Pulse angiography system in Europe after receiving CE mark approval, expanding its presence in the European interventional imaging market.

Future Outlook

Angiography Equipment Market Future Outlook

The Angiography Equipment Market is projected to grow at a 5.2% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of portable angiography systems for remote diagnostics.
  • Integration of AI for enhanced imaging analysis and workflow efficiency.
  • Expansion into emerging markets with tailored financing solutions.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

Market Segmentation

Angiography Equipment Market End Use Outlook

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Research Institutions

Angiography Equipment Market Technology Outlook

  • Digital Angiography
  • Computed Tomography Angiography
  • Magnetic Resonance Angiography
  • Fluoroscopy

Angiography Equipment Market Application Outlook

  • Cardiovascular
  • Neurovascular
  • Peripheral
  • Oncology
  • Gastrointestinal

Angiography Equipment Market Product Type Outlook

  • Angiography Systems
  • Angiography Catheters
  • Angiography Contrast Media
  • Angiography Accessories

Report Scope

MARKET SIZE 2024 9.41(USD Billion)
MARKET SIZE 2025 9.89(USD Billion)
MARKET SIZE 2035 16.43(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.2% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Medtronic (US), Boston Scientific (US), Fujifilm (JP), Hitachi Medical Systems (JP), Hologic (US)
Segments Covered Application, End Use, Product Type, Technology
Key Market Opportunities Integration of artificial intelligence in Angiography Equipment enhances diagnostic accuracy and operational efficiency.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the angiography equipment market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Angiography Equipment Market in 2025?

The Angiography Equipment Market is valued at approximately 9.41 USD Billion in 2024.

What is the projected market size for the Angiography Equipment Market by 2035?

The market is projected to reach around 16.43 USD Billion by 2035.

What is the expected CAGR for the Angiography Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the Angiography Equipment Market during the forecast period 2025 - 2035 is 5.2%.

Which companies are the key players in the Angiography Equipment Market?

Key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.

What are the primary applications of angiography equipment?

The primary applications include Cardiovascular, Neurovascular, Peripheral, Oncology, and Gastrointestinal, with valuations ranging from 1.0 to 5.2 USD Billion.

How does the market segment by end use look in 2025?

In 2025, the market segments by end use include Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Research Institutions.

What product types are included in the Angiography Equipment Market?

The market includes Angiography Systems, Angiography Catheters, Angiography Contrast Media, and Angiography Accessories.

What technologies are utilized in the Angiography Equipment Market?

Technologies utilized include Digital Angiography, Computed Tomography Angiography, Magnetic Resonance Angiography, and Fluoroscopy.

How does the patient demographic segmentation appear in the Angiography Equipment Market?

The patient demographic segmentation includes Adult, Pediatric, and Geriatric categories, with valuations from 1.5 to 8.5 USD Billion.

What trends are anticipated in the Angiography Equipment Market by 2035?

By 2035, trends may indicate increased adoption of advanced technologies and a growing focus on patient-specific solutions.
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Co-Author
Co-Author Profile
Kinjoll Dey LinkedIn
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Coordination Group (MDCG), International Atomic Energy Agency (IAEA) Radiation Safety Database, Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), American College of Cardiology (ACC), American Heart Association (AHA), European Society of Cardiology (ESC), National Institutes of Health (NIH) ClinicalTrials.gov, National Center for Biotechnology Information (NCBI/PubMed), World Health Organization (WHO) Cardiovascular Disease Database, OECD Health Statistics, EU Eurostat Healthcare Expenditure Database, and national health ministry reports from key markets (China NMPA, Japan PMDA, India CDSCO). These sources were used to collect procedure statistics, regulatory approval data (510(k), PMA, CE mark), clinical safety studies, demographic trends, and market landscape analysis for angiography systems, angiography catheters, contrast media, vascular closure devices, angiography balloons, guidewires, and accessories.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. From angiography equipment manufacturers, imaging system OEMs, and contrast media producers, supply-side sources comprised CEOs, VPs of Product Development, regulatory affairs leaders, and commercial directors. Interventional cardiologists, neuroradiologists, vascular surgeons, cath lab directors, procurement leaders from hospitals and clinics, diagnostic center administrators, imaging center managers, and research institute principal investigators comprised demand-side sources. In order to validate market segmentation, primary research was conducted across product types (systems, catheters, contrast media, VCDs, balloons, guidewires, accessories), procedure categories (coronary, endovascular, neuroangiography, onco-angiography), application areas (diagnostics, therapeutics), and end-user settings (hospitals & clinics, diagnostic centers, imaging centers, research institutes). Additionally, it verified the timelines of the product pipeline and collected information on clinical adoption patterns, pricing strategies, reimbursement dynamics, and technology transitions (fluoroscopy, digital angiography, CT angiography, and MR angiography).

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping, procedure volume analysis, and installed base assessment. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America

Product mapping across angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories

Technology-level mapping across digital angiography, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and fluoroscopy systems

Procedure-level mapping across coronary angiography, endovascular angiography, neuroangiography, and onco-angiography

Analysis of reported and modeled annual revenues specific to angiography equipment portfolios

Coverage of manufacturers representing 75–80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country/region, installed base × service contract value, and consumables volume × unit price) and top-down (manufacturer revenue validation, segment allocation by product mix) approaches to derive segment-specific valuations for each product, procedure, application, end-user, and technology category

Key distinctions from your original dermal filler methodology:

Table

Aspect Dermal Fillers Angiography Equipment

Regulatory focus FDA/CDER, EMA/ATMP FDA/CDRH, EMA/MDCG, IAEA

Clinical societies ISAPS, ASDS, ASPS SCAI, SIR, ACC, AHA, ESC

Product categories HA, CaHA, PLLA fillers Systems, catheters, contrast, VCDs, balloons, guidewires, accessories

Procedure types Aesthetic injections Coronary, endovascular, neuro, onco-angiography

Technology layers Not applicable Digital angiography, CTA, MRA, fluoroscopy

End-user settings Med spas, dermatology clinics Hospitals, diagnostic centers, imaging centers, research institutes

Primary respondents (supply) Aesthetic device/filler manufacturers Imaging system OEMs, contrast media producers, interventional device manufacturers

Primary respondents (demand) Dermatologists, plastic surgeons, med spa directors Interventional cardiologists, neuroradiologists, vascular surgeons, cath lab directors

Manufacturer coverage 45+ manufacturers, 70–75% share 50+ manufacturers, 75–80% share

Market size base year 2024 2024 (USD 9.41B)

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.